These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15265500)

  • 1. Inhibitors of the glycine transporter type-2 (GlyT-2): synthesis and biological activity of benzoylpiperidine derivatives.
    Wolin RL; Santillán A; Tang L; Huang C; Jiang X; Lovenberg TW
    Bioorg Med Chem; 2004 Aug; 12(16):4511-32. PubMed ID: 15265500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel glycine transporter type-2 reuptake inhibitors. Part 1: alpha-amino acid derivatives.
    Wolin RL; Venkatesan H; Tang L; Santillán A; Barclay T; Wilson S; Lee DH; Lovenberg TW
    Bioorg Med Chem; 2004 Aug; 12(16):4477-92. PubMed ID: 15265498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel glycine transporter type-2 reuptake inhibitors. Part 2: beta- and gamma-amino acid derivatives.
    Wolin RL; Santillán A; Barclay T; Tang L; Venkatesan H; Wilson S; Lee DH; Lovenberg TW
    Bioorg Med Chem; 2004 Aug; 12(16):4493-509. PubMed ID: 15265499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The synthesis and SAR of 2-arylsulfanyl-phenyl piperazinyl acetic acids as glyT-1 inhibitors.
    Smith G; Ruhland T; Mikkelsen G; Andersen K; Christoffersen CT; Alifrangis LH; Mørk A; Wren SP; Harris N; Wyman BM; Brandt G
    Bioorg Med Chem Lett; 2004 Aug; 14(15):4027-30. PubMed ID: 15225720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery and characterization of potent small molecule inhibitors of the high affinity proline transporter.
    Yu XC; Zhang W; Oldham A; Buxton E; Patel S; Nghi N; Tran D; Lanthorn TH; Bomont C; Shi ZC; Liu Q
    Neurosci Lett; 2009 Feb; 451(3):212-6. PubMed ID: 19159658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irreversible inhibition of [3H]glycine transport into channel catfish erythrocytes by thiol group modifiers.
    McCormick SJ; Tunnicliff G
    Pharmacology; 2004 Mar; 70(3):113-7. PubMed ID: 14752230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of GlyT1 affect glycine transport via discrete binding sites.
    Mezler M; Hornberger W; Mueller R; Schmidt M; Amberg W; Braje W; Ochse M; Schoemaker H; Behl B
    Mol Pharmacol; 2008 Dec; 74(6):1705-15. PubMed ID: 18815213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of a fluorescent imaging plate reader membrane potential assay for high-throughput screening of glycine transporter modulators.
    Benjamin ER; Skelton J; Hanway D; Olanrewaju S; Pruthi F; Ilyin VI; Lavery D; Victory SF; Valenzano KJ
    J Biomol Screen; 2005 Jun; 10(4):365-73. PubMed ID: 15964938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycine transporters: essential regulators of neurotransmission.
    Eulenburg V; Armsen W; Betz H; Gomeza J
    Trends Biochem Sci; 2005 Jun; 30(6):325-33. PubMed ID: 15950877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycine transporter isoforms in the mammalian central nervous system: structures, functions and therapeutic promises.
    Gomeza J; Ohno K; Betz H
    Curr Opin Drug Discov Devel; 2003 Sep; 6(5):675-82. PubMed ID: 14579517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The synthesis and SAR of 2-arylsulfanylphenyl-1-oxyalkylamino acids as GlyT-1 inhibitors.
    Smith G; Mikkelsen G; Eskildsen J; Bundgaard C
    Bioorg Med Chem Lett; 2006 Aug; 16(15):3981-4. PubMed ID: 16725323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel triple reuptake inhibitors with low risk of CAD associated liabilities: design, synthesis and biological activities of 4-[(1S)-1-(3,4-dichlorophenyl)-2-methoxyethyl]piperidine and related compounds.
    Ishichi Y; Kimura E; Honda E; Yoshikawa M; Nakahata T; Terao Y; Suzuki A; Kawai T; Arakawa Y; Ohta H; Kanzaki N; Nakagawa H; Terauchi J
    Bioorg Med Chem; 2013 Aug; 21(15):4600-13. PubMed ID: 23769168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of glycine receptor and transporter on bullfrog retinal Müller cells.
    Lee SC; Zhong YM; Yang XL
    Neurosci Lett; 2005 Oct; 387(2):75-9. PubMed ID: 16084022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycinergic neurons expressing enhanced green fluorescent protein in bacterial artificial chromosome transgenic mice.
    Zeilhofer HU; Studler B; Arabadzisz D; Schweizer C; Ahmadi S; Layh B; Bösl MR; Fritschy JM
    J Comp Neurol; 2005 Feb; 482(2):123-41. PubMed ID: 15611994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acylglycinamides as inhibitors of glycine transporter type 1.
    Blunt R; Porter R; Johns A; Nash D; Puckey G; Wyman P; Herdon H; Teague S; Hadden V; Fontana S; Gordon L
    Bioorg Med Chem Lett; 2011 Oct; 21(20):6176-9. PubMed ID: 21889344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-(Aminomethyl)-benzamide-based glycine transporter type-2 inhibitors.
    Ho KK; Appell KC; Baldwin JJ; Bohnstedt AC; Dong G; Guo T; Horlick R; Islam KR; Kultgen SG; Masterson CM; McDonald E; McMillan K; Morphy JR; Rankovic Z; Sundaram H; Webb M
    Bioorg Med Chem Lett; 2004 Jan; 14(2):545-8. PubMed ID: 14698200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-Chloro-N-[(S)-phenyl [(2S)-piperidin-2-yl] methyl]-3-trifluoromethyl benzamide, monohydrochloride, an inhibitor of the glycine transporter type 1, increases evoked-dopamine release in the rat nucleus accumbens in vivo via an enhanced glutamatergic neurotransmission.
    Leonetti M; Desvignes C; Bougault I; Souilhac J; Oury-Donat F; Steinberg R
    Neuroscience; 2006; 137(2):555-64. PubMed ID: 16289893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional expression of the glycine transporter 1 on bullfrog retinal cones.
    Zhang XJ; Ge LH; Liu J; Yang XL
    Neuroreport; 2008 Nov; 19(17):1667-71. PubMed ID: 18841092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trafficking properties and activity regulation of the neuronal glycine transporter GLYT2 by protein kinase C.
    Fornés A; Núñez E; Alonso-Torres P; Aragón C; López-Corcuera B
    Biochem J; 2008 Jun; 412(3):495-506. PubMed ID: 18341477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the glycine transport system GLYT 1 in human placental choriocarcinoma cells (JAR).
    Liu W; Leibach FH; Ganapathy V
    Biochim Biophys Acta; 1994 Aug; 1194(1):176-84. PubMed ID: 8075134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.